Pneumococcal 15-Valent Conjugate Vaccine Approved for Pediatric Use
For children, Vaxneuvance is administered as a 4-dose series at 2, 4, 6 and 12 through 15 months of age (and at least 2 months after the 3rd dose).
Pneumonia
Long-COVID Lung Disease: Researchers Characterize 3 Phenotypes
Can long-COVID lung diseases be better understood and classified via analysis of abnormalities seen on transbronchial lung cryobiopsies?
Pulmonary Impairment 1 Year Post COVID-19 Pneumonia
What kinds of pulmonary sequelae do patients experience a year after hospitalization with COVID-19 pneumonia — and does the level of ventilatory support matter?
Short Course of Antibiotics in Children With Community-Acquired Pneumonia
Can nonsevere childhood community-acquired pneumonia be effectively treated by a short course of antibiotics?
ACIP: 2022 Adult Immunization Schedule Updates
The 2022 adult immunization schedule summarizes ACIP recommendations, including several changes.
Venous Thromboembolism, Methylprednisolone, and Heparin in COVID-19 Pneumonia
How does methylprednisolone dose and duration affect rates of VTE and mortality among patients with COVID-19 pneumonia?
Shorter Antibiotic Course Safe, Effective for Uncomplicated Childhood CAP
The randomized, double-blind, placebo-controlled study included a total of 380 patients aged 6 to 71 months with nonsevere CAP.
Xenleta Now Available in New Oral Pack for Community-Acquired Bacterial Pneumonia
The new 10-count packaging provides convenience for patients and health care professionals with a complete 5-day course of treatment.
ACIP Recommends Updates to Pneumococcal Vaccination Guidelines
The update applies to patients who have not previously received a pneumococcal conjugate vaccine or whose previous vaccination history is unknown.
Prevnar 20 Coadministered With Flu Vaccine Immunogenic, Safe in Older Adults
The randomized, double-blind trial enrolled a total of 1796 participants, of which 1727 completed the study.
- Loading...
Loading...
Loading... 
Loading...